Skip to main content
TipRanks
Go Ultimate75% OFF

Ryvu Therapeutics SA (0RKT) Income Statement

0 Followers

Ryvu Therapeutics SA Income Statement

Last quarter (Q2 2026), Ryvu Therapeutics SA's total revenue was zł11.99M, a decrease of 3.35% from the same quarter last year. In Q2, Ryvu Therapeutics SA's net income was zł-13.06M. See Ryvu Therapeutics SA’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
zł 62.25Mzł 77.97Mzł 46.86Mzł 38.80Mzł 11.19M
zł -117.03Mzł 58.39Mzł 29.31Mzł 21.40Mzł -2.54M
zł 5.12Mzł 180.49Mzł 130.25Mzł 93.07Mzł 75.98M
Depreciation and Amortizationzł 9.44Mzł 10.49Mzł 10.97Mzł 12.90Mzł 12.56M
zł -112.71Mzł -96.83Mzł -81.04Mzł -65.21Mzł -65.96M
zł -122.15Mzł -122.10Mzł -100.95Mzł -78.42Mzł -103.78M
zł 21.01Mzł 10.96Mzł 8.84Mzł -773.00Kzł -363.00K
zł -101.14Mzł -111.14Mzł -92.11Mzł -79.19Mzł -78.96M
zł -101.23Mzł -111.44Mzł -92.11Mzł -83.78Mzł -79.08M
Per Share Metrics
Basic EPSzł -4.38zł -4.82zł -4.02zł -4.57zł -4.31
Diluted EPSzł -4.38zł -4.82zł -4.02zł -4.57zł -4.31
Weighted Average Shares Outstanding23.12M23.12M22.90M18.33M18.36M
Weighted Average Shares Outstanding (Diluted)23.12M23.12M22.90M18.33M18.36M

Currency in PLN

Ryvu Therapeutics SA Earnings and Revenue History

-200M-100M0100M-800 %-400 %0 %400 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin